These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21216198)

  • 1. Dutasteride for spinal and bulbar muscular atrophy.
    Banno H; Katsuno M; Suzuki K; Sobue G
    Lancet Neurol; 2011 Feb; 10(2):113-5. PubMed ID: 21216198
    [No Abstract]   [Full Text] [Related]  

  • 2. A severe phenotype of Kennedy disease associated with a very large CAG repeat expansion.
    Madeira JLO; Souza ABC; Cunha FS; Batista RL; Gomes NL; Rodrigues AS; Mennucci de Haidar Jorge F; Chadi G; Callegaro D; Mendonca BB; Costa EMF; Domenice S
    Muscle Nerve; 2018 Jan; 57(1):E95-E97. PubMed ID: 28877561
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy.
    Katsuno M; Banno H; Suzuki K; Adachi H; Tanaka F; Sobue G
    Arch Neurol; 2012 Apr; 69(4):436-40. PubMed ID: 22158719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.
    Breza M; Koutsis G
    J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.
    Fernández-Rhodes LE; Kokkinis AD; White MJ; Watts CA; Auh S; Jeffries NO; Shrader JA; Lehky TJ; Li L; Ryder JE; Levy EW; Solomon BI; Harris-Love MO; La Pean A; Schindler AB; Chen C; Di Prospero NA; Fischbeck KH
    Lancet Neurol; 2011 Feb; 10(2):140-7. PubMed ID: 21216197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the CAG repeat size and electrophysiological findings in patients with spinal and bulbar muscular atrophy.
    Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK
    Muscle Nerve; 2018 Apr; 57(4):683-686. PubMed ID: 28972672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kennedy's disease: clinical significance of tandem repeats in the androgen receptor.
    Zajac JD; Fui MN
    Adv Exp Med Biol; 2012; 769():153-68. PubMed ID: 23560310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal and Bulbar Muscular Atrophy Overview.
    Fischbeck KH
    J Mol Neurosci; 2016 Mar; 58(3):317-20. PubMed ID: 26547319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials.
    Hama T; Hirayama M; Hara T; Nakamura T; Atsuta N; Banno H; Suzuki K; Katsuno M; Tanaka F; Sobue G
    Muscle Nerve; 2012 Feb; 45(2):169-74. PubMed ID: 22246870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the androgen receptor CAG repeat polymorphism in prostate cancer, and spinal and bulbar muscular atrophy.
    Kumar R; Atamna H; Zakharov MN; Bhasin S; Khan SH; Jasuja R
    Life Sci; 2011 Mar; 88(13-14):565-71. PubMed ID: 21284948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy.
    Bott LC; Badders NM; Chen KL; Harmison GG; Bautista E; Shih CC; Katsuno M; Sobue G; Taylor JP; Dantuma NP; Fischbeck KH; Rinaldi C
    Hum Mol Genet; 2016 May; 25(10):1979-1989. PubMed ID: 26962150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)].
    Suzuki K; Banno H; Katsuno M; Adachi H; Tanaka F; Sobue G
    Brain Nerve; 2012 Mar; 64(3):237-44. PubMed ID: 22402717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal and Bulbar Muscular Atrophy.
    Grunseich C; Fischbeck KH
    Neurol Clin; 2015 Nov; 33(4):847-54. PubMed ID: 26515625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal and bulbar muscular atrophy: a motoneuron or muscle disease?
    Jordan CL; Lieberman AP
    Curr Opin Pharmacol; 2008 Dec; 8(6):752-8. PubMed ID: 18775514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic differences in a large family with Kennedy's disease from the Middle Black Sea region of Turkey.
    Karaer H; Kaplan Y; Kurt S; Gundogdu A; Erdoğan B; Başak NA
    Amyotroph Lateral Scler; 2010; 11(1-2):148-53. PubMed ID: 20184516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of spinal bulbar muscular atrophy (Kennedy's disease) and avenues for treatment.
    Grunseich C; Fischbeck KH
    Curr Opin Neurol; 2020 Oct; 33(5):629-634. PubMed ID: 32773451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of spinal and bulbar muscular atrophy with high-stage and high-Gleason Score prostate cancer responded to maximal androgen blockade therapy.
    Kosaka T; Miyajima A; Kikuchi E; Takahashi S; Suzuki N; Oya M
    J Androl; 2012; 33(4):563-5. PubMed ID: 21940987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kennedy's disease and partial androgen insensitivity syndrome. Report of 4 cases and literature review.
    Valera Yepes R; Virgili Casas M; Povedano Panades M; Guerrero Gual M; Villabona Artero C
    Endocrinol Nutr; 2015 May; 62(5):224-30. PubMed ID: 25857692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of androgen receptor polyQ chain elongation in Kennedy's disease and use of natural osmolytes as potential therapeutic targets.
    Kumar R
    IUBMB Life; 2012 Nov; 64(11):879-84. PubMed ID: 23024039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
    Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
    Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.